Cannabis Reform Emerges as 2026 Campaign Issue Across U.S. Races

Federal Rescheduling Stalemate Drives Campaign Focus

The DEA's failure to finalize cannabis rescheduling by the August 2026 administrative deadline has turned federal drug policy into a wedge issue for Senate and House challengers. The Drug Enforcement Administration published a Notice of Proposed Rulemaking in May 2024 to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, but final action remains pending after more than two years of public comment and administrative review.

Candidates in Arizona, Pennsylvania, and Nevada Senate races have issued position statements on rescheduling in the past 30 days, according to campaign filings. Democratic challengers are using the delay to attack Republican incumbents who opposed the SAFER Banking Act in 2023. Some GOP candidates are now endorsing state-level legalization to blunt the attack.

Seven States Face November Cannabis Ballot Measures

Voters in Florida, North Dakota, South Dakota, Nebraska, Idaho, Arkansas, and Oklahoma will decide cannabis legalization or reform measures on November 3, 2026. Florida's Amendment 3, which would authorize adult-use sales under the state's existing medical framework, has drawn $42 million in combined spending from Trulieve and the Republican Party of Florida, which opposes the measure.

The ballot-measure calendar is shaping gubernatorial and state legislative races:

• Florida Governor Ron DeSantis has campaigned against Amendment 3, while Democratic challenger Nikki Fried supports it.
• North Dakota's Measure 5 would create a state-run dispensary system; both major-party gubernatorial candidates have endorsed it.
• Nebraska's Initiative 437 would legalize medical cannabis; the state's Republican attorney general has challenged its ballot language in court.

Polling Shows Bipartisan Majority Support in Swing States

A Pew Research Center survey conducted in July 2026 found 68 percent of U.S. adults support legalizing cannabis for adult use, including 51 percent of self-identified Republicans. In Arizona, Pennsylvania, and Georgia—three states with competitive Senate races—support for legalization exceeds 60 percent across party lines, according to state-level polling by Morning Consult.

That shift is visible in campaign advertising. Democratic Senatorial Campaign Committee ads in Pennsylvania reference Republican Senator Pat Toomey's 2023 vote against the SAFER Banking Act, which would've allowed state-licensed cannabis businesses to access federal banking services. Toomey hasn't responded publicly to the ads.

House Races in California and New York Feature Cannabis Attacks

At least four competitive House races in California and New York have featured cannabis-policy attacks in the past 60 days, targeting incumbents over tax policy and enforcement. In California's 13th District, Republican challenger John Duarte has criticized Democratic Representative Josh Harder for supporting federal legalization without addressing Section 280E of the Internal Revenue Code, which prohibits cannabis businesses from deducting ordinary business expenses.

Pat Ryan, the Democrat in New York's 19th District, has attacked Republican challenger Alison Esposito over her opposition to the state's 2021 Marihuana Regulation and Taxation Act, which legalized adult-use sales. Esposito, a former NYPD officer, has called for stricter impaired-driving enforcement but hasn't endorsed repeal.

The political calculus has shifted: opposing cannabis reform is now riskier than supporting it in most swing districts.

Presidential Candidates Avoid Federal Legalization Commitments

Neither major-party presidential nominee has endorsed federal legalization of adult-use cannabis, despite bipartisan polling support. Vice President Kamala Harris, the Democratic nominee, has endorsed rescheduling to Schedule III and expungement of prior federal possession convictions. Former President Donald Trump, the Republican nominee, hasn't issued a 2026 campaign statement on cannabis policy; his 2020 platform opposed legalization.

Third-party candidates, including Libertarian Chase Oliver and Green Party nominee Jill Stein, have endorsed full federal descheduling and expungement. Neither has polled above 3 percent nationally.

State-Level Candidates Use Cannabis to Court Young Voters

Gubernatorial and state legislative candidates in Michigan, Colorado, and Illinois are using cannabis-revenue promises to appeal to voters under 35, a demographic that supports legalization at rates exceeding 75 percent. Michigan Governor Gretchen Whitmer, running for reelection, has proposed using cannabis excise-tax revenue to fund community-college tuition waivers—a policy her Republican challenger hasn't addressed.

Democratic candidates for the Illinois state House have proposed redirecting a portion of the state's cannabis tax revenue from general funds to municipal infrastructure projects in districts with high rates of prior cannabis arrests. Illinois collected $445 million in cannabis tax revenue in fiscal year 2025, according to the Illinois Department of Revenue.

What Happens After November

If Democrats retain or expand their Senate majority, cannabis-reform advocates expect floor votes on the SAFER Banking Act and a federal expungement bill in the first quarter of 2027. If Republicans take the Senate, the path forward depends on whether GOP leadership allows state-level legalization advocates within the caucus to advance banking reform without broader legalization provisions.

For a full analysis of how federal rescheduling intersects with campaign politics, see the CannIntel topic hub on Cannabis in 2026 Campaign Politics. The next signal: whether the DEA issues a final rescheduling rule before the November election, or punts to the next administration.